| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A Case Report of Anorectal Squamous Cell Carcinoma Associated with Overlap Myositis Syndrome—a Possible Paraneoplastic Myositis Syndrome
|
Bosma, Nicholas A.
|
|
|
20 |
2 |
p. 148-152
|
article
|
| 2 |
Association of Metformin, Other Antidiabetic Medications, and Statins With Incidence of Colon Cancer in Patients With Type 2 Diabetes
|
Erkinantti, Sami
|
|
|
20 |
2 |
p. e113-e119
|
article
|
| 3 |
Benefit of Oxaliplatin in Stage III Colon Cancer According to IDEA Risk Groups: Findings from the ACCENT Database of 4934 Patients
|
Margalit, Ofer
|
|
|
20 |
2 |
p. 130-136
|
article
|
| 4 |
B7-H3 and PD-L1 Expression Are Prognostic Biomarkers in a Multi-racial Cohort of Patients with Colorectal Cancer
|
Zhang, Wei
|
|
|
20 |
2 |
p. 161-169
|
article
|
| 5 |
Colorectal Adenocarcinoma Presenting With Isolated Metastasis to the Cortical Bone and Bone Marrow: A Case Report and Review of the Literature
|
Ripp, Jacob
|
|
|
20 |
2 |
p. e150-e154
|
article
|
| 6 |
Comparative Effectiveness of Total Neoadjuvant Therapy Versus Standard Adjuvant Chemotherapy for Locally Advanced Rectal Cancer
|
Yu, Shun
|
|
|
20 |
2 |
p. 121-129
|
article
|
| 7 |
Editorial Board
|
|
|
|
20 |
2 |
p. A1
|
article
|
| 8 |
Effectiveness of Combining Bevacizumab With First-Line Chemotherapy Regimens for Metastatic Colorectal Cancer in Real-World Practice
|
Bang, Yeong Hak
|
|
|
20 |
2 |
p. 101-112.e6
|
article
|
| 9 |
Epidemiology and Molecular-Pathologic Characteristics of CpG Island Methylator Phenotype (CIMP) in Colorectal Cancer
|
Advani, Shailesh M.
|
|
|
20 |
2 |
p. 137-147.e1
|
article
|
| 10 |
Factors Associated With Local Tumor Control and Complications After Thermal Ablation of Colorectal Cancer Liver Metastases: A 15-year Retrospective Cohort Study
|
Kurilova, Ieva
|
|
|
20 |
2 |
p. e82-e95
|
article
|
| 11 |
Genetic Characteristics of Colorectal Neuroendocrine Carcinoma: More Similar to Colorectal Adenocarcinoma
|
Chen, Luohai
|
|
|
20 |
2 |
p. 177-185.e13
|
article
|
| 12 |
Multicohort Retrospective Validation of a Predictive Biomarker for Topoisomerase I Inhibitors
|
Ando, Koji
|
|
|
20 |
2 |
p. e129-e138
|
article
|
| 13 |
Neoadjuvant Immunotherapy in Microsatellite-Instability High Nonmetastatic Colorectal Cancer: A Single-institute Experience and Review of the Literature
|
Kinney, Rachel E.
|
|
|
20 |
2 |
p. e109-e112
|
article
|
| 14 |
Neuroendocrine Carcinoma of the Anus and Rectum: Patient Characteristics and Treatment Options
|
Ueberroth, Benjamin E.
|
|
|
20 |
2 |
p. e139-e149
|
article
|
| 15 |
Occurrence and Management of Thrombocytopenia in Metastatic Colorectal Cancer Patients Receiving Chemotherapy: Secondary Analysis of Data From Prospective Clinical Trials
|
Kilpatrick, Karynsa
|
|
|
20 |
2 |
p. 170-176
|
article
|
| 16 |
Pathologic Complete Response in Patient With ATM Mutation After Neoadjuvant FOLFOXIRI Plus Panitumumab Therapy for Locally Advanced Colon Cancer: A Case Report
|
McGillivray, Erin
|
|
|
20 |
2 |
p. e96-e99
|
article
|
| 17 |
Prognostic Value and Molecular Landscape of HER2 Low-Expressing Metastatic Colorectal Cancer
|
Yagisawa, Masataka
|
|
|
20 |
2 |
p. 113-120.e1
|
article
|
| 18 |
Real-world Data for High-risk Stage II Colorectal Cancer – The Role of Tumor Side in the Adjuvant Setting
|
Araujo, Camila S.
|
|
|
20 |
2 |
p. e100-e108
|
article
|
| 19 |
Real-world Safety and Efficacy of Raltitrexed in Patients With Metastatic Colorectal Cancer
|
Batra, Atul
|
|
|
20 |
2 |
p. e75-e81
|
article
|
| 20 |
Safety and Efficacy of 7 Days on/7 Days off Versus 14 Days on/7 Days off Schedules of Capecitabine in Patients with Metastatic Colorectal Cancer: A Retrospective Review
|
Bryson, Evan
|
|
|
20 |
2 |
p. 153-160
|
article
|
| 21 |
Table of contents
|
|
|
|
20 |
2 |
p. A3-A6
|
article
|
| 22 |
The Impact of Changes in Service Delivery in Patients With Colorectal Cancer During the Initial Phase of the COVID-19 Pandemic
|
Kamposioras, Konstantinos
|
|
|
20 |
2 |
p. e120-e128
|
article
|
Journal description